<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lass-Florl C</submitter><funding>Christian Doppler Forschungsgesellschaft (CDG)</funding><funding>Christian Doppler Forschungsgesellschaft</funding><pagination>e0031120</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8404697</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(4)</volume><pubmed_abstract>Infections due to &lt;i>Aspergillus&lt;/i> species are an acute threat to human health; members of the &lt;i>Aspergillus&lt;/i> section &lt;i>Fumigati&lt;/i> are the most frequently occurring agents, but depending on the local epidemiology, representatives of section &lt;i>Terrei&lt;/i> or section &lt;i>Flavi&lt;/i> are the second or third most important. &lt;i>Aspergillus terreus&lt;/i> species complex is of great interest, as it is usually amphotericin B resistant and displays notable differences in immune interactions in comparison to &lt;i>Aspergillus fumigatus&lt;/i>. The latest epidemiological surveys show an increased incidence of &lt;i>A. terreus&lt;/i> as well as an expanding clinical spectrum (chronic infections) and new groups of at-risk patients being affected. Hallmarks of these non-&lt;i>Aspergillus fumigatus&lt;/i> invasive mold infections are high potential for tissue invasion, dissemination, and possible morbidity due to mycotoxin production. We seek to review the microbiology, epidemiology, and pathogenesis of &lt;i>A. terreus&lt;/i> species complex, address clinical characteristics, and highlight the underlying mechanisms of amphotericin B resistance. Selected topics will contrast key elements of &lt;i>A. terreus&lt;/i> with &lt;i>A. fumigatus&lt;/i>. We provide a comprehensive resource for clinicians dealing with fungal infections and researchers working on &lt;i>A. terreus&lt;/i> pathogenesis, aiming to bridge the emerging translational knowledge and future therapeutic challenges on this opportunistic pathogen.</pubmed_abstract><journal>Clinical microbiology reviews</journal><pubmed_title>Aspergillus terreus Species Complex.</pubmed_title><pmcid>PMC8404697</pmcid><funding_grant_id>CD-Laboratory for Invasive Fungal Infections</funding_grant_id><pubmed_authors>Kontoyiannis DP</pubmed_authors><pubmed_authors>Lass-Florl C</pubmed_authors><pubmed_authors>Brock M</pubmed_authors><pubmed_authors>Dietl AM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Aspergillus terreus Species Complex.</name><description>Infections due to &lt;i>Aspergillus&lt;/i> species are an acute threat to human health; members of the &lt;i>Aspergillus&lt;/i> section &lt;i>Fumigati&lt;/i> are the most frequently occurring agents, but depending on the local epidemiology, representatives of section &lt;i>Terrei&lt;/i> or section &lt;i>Flavi&lt;/i> are the second or third most important. &lt;i>Aspergillus terreus&lt;/i> species complex is of great interest, as it is usually amphotericin B resistant and displays notable differences in immune interactions in comparison to &lt;i>Aspergillus fumigatus&lt;/i>. The latest epidemiological surveys show an increased incidence of &lt;i>A. terreus&lt;/i> as well as an expanding clinical spectrum (chronic infections) and new groups of at-risk patients being affected. Hallmarks of these non-&lt;i>Aspergillus fumigatus&lt;/i> invasive mold infections are high potential for tissue invasion, dissemination, and possible morbidity due to mycotoxin production. We seek to review the microbiology, epidemiology, and pathogenesis of &lt;i>A. terreus&lt;/i> species complex, address clinical characteristics, and highlight the underlying mechanisms of amphotericin B resistance. Selected topics will contrast key elements of &lt;i>A. terreus&lt;/i> with &lt;i>A. fumigatus&lt;/i>. We provide a comprehensive resource for clinicians dealing with fungal infections and researchers working on &lt;i>A. terreus&lt;/i> pathogenesis, aiming to bridge the emerging translational knowledge and future therapeutic challenges on this opportunistic pathogen.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-05-29T16:11:22.104Z</modification><creation>2025-04-22T16:33:39.354Z</creation></dates><accession>S-EPMC8404697</accession><cross_references><pubmed>34190571</pubmed><doi>10.1128/CMR.00311-20</doi><doi>10.1128/cmr.00311-20</doi></cross_references></HashMap>